Featured News

1

New-Generation Machine Headlines Major Expansion at Precision...

December 20, 2011

Acquisition of a new-generation linear accelerator is included in a significant expansion under way at the Precision Radiotherapy Center, a state-of-the-art radiotherapy/radiosurgery treatment center for people with cancer, benign tumors and other abnormalities.

2

Focus on Science With Terry Kirley, PhD

December 15, 2011

Terry Kirley, PhD, is a professor in the department of pharmacology and cell biophysics. His research focuses on the study of the structure, function and clinical applications of ecto-nucleotidases enzyme families that modulate and control many physiological processes, including blood coagulation, smooth muscle contraction, inflammatory responses and pain perception.

3

UC Doctor Chairs IOM Committee on 'Modified Risk' Tobacco...

December 14, 2011

A new Institute of Medicine report specifies the types of research that the Food and Drug Administration should require before allowing tobacco companies to sell or advertise 'modified risk' tobacco products as being capable of reducing the health risks of tobacco use.

Debug Query for this

Latest News

1

New-Generation Machine Headlines Major Expansion at Precision...

December 20, 2011

Acquisition of a new-generation linear accelerator is included in a significant expansion under way at the Precision Radiotherapy Center, a state-of-the-art radiotherapy/radiosurgery treatment center for people with cancer, benign tumors and other abnormalities.

2

Focus on Science With Terry Kirley, PhD

December 15, 2011

Terry Kirley, PhD, is a professor in the department of pharmacology and cell biophysics. His research focuses on the study of the structure, function and clinical applications of ecto-nucleotidases enzyme families that modulate and control many physiological processes, including blood coagulation, smooth muscle contraction, inflammatory responses and pain perception.

3

UC Doctor Chairs IOM Committee on 'Modified Risk' Tobacco...

December 14, 2011

A new Institute of Medicine report specifies the types of research that the Food and Drug Administration should require before allowing tobacco companies to sell or advertise 'modified risk' tobacco products as being capable of reducing the health risks of tobacco use.

5

Master's of Public Health Program Moves to Environmental Health

December 14, 2011

With the transition of the Master s of Public Health (MPH) program to the department of environmental health, which is chaired by Shuk-mei Ho, PhD, Bill Mase, DrPH, program director, says this change essentially means a more robust program for students who come to UC for public health training.

6

UC Doctor Chairs IOM Committee on Modified Risk Tobacco...

December 14, 2011

A new Institute of Medicine report specifies the types of research that the Food and Drug Administration should require before allowing tobacco companies to sell or advertise modified risk tobacco products as being capable of reducing the health risks of tobacco use.

8

Benefit Concert's Value Goes Beyond Money

December 8, 2011

Talent filled Kresge Auditorium Dec. 2 at the 2011 IvaDean Scholarship Benefit Concert, and entrance fees, gifts on behalf of the concert and silent auction bids brought in $3,378 for the scholarship fund. But the meaning of this event and its namesake, College of Medicine assistant dean IvaDean Lair, goes beyond money for many students.

11

Study Looks at Human Health Effects of 'Green Housing'

December 5, 2011

It is thought that the benefits of the green movement could go beyond environmental sustainability to directly impact human health. A new UC study seeks to measure the potential health benefits of "green" practices in housing.

Load More
Debug Query for this